GDPO promotes evidence based drug policy through reporting, monitoring and analysis of global policy developments
Worrying proposals to discuss the international scheduling of Ketamine at the CND in March 2015
As noted in the 2014 TNI – IDPC report Scheduling in the international drug control system, although often viewed as an obscure technical issue, the problem of scheduling lies at the core of the functioning of the international drug control system. Scheduling – the classification of a substance within a graded system of controls and restrictions, or ‘schedules’ – must take place in order for a substance to be included in the international control framework, and determines the type and intensity of controls to be applied. For this reason, the topic is of central importance. Within this context, recent years have seen ketamine become an increasing point of contention. Concerned by ‘recreational use’, some states, China key among them, have been pushing for international control of the drug. This goes against repeated recommendations from the WHO, the body responsible for providing expert guidance on scheduling decisions within the UN Commission on Narcotic Drugs (CND). As the WHO points out, while some non-medical use certainly takes place within some parts of the world, international scheduling would likely have damaging consequences on medical access to the drug (a WHO listed essential medicine) in developing countries. Here it is the only available anaesthetic for essential surgery in most rural areas.
This Fact Sheet on the Proposal to Discuss International Scheduling of Ketamine at the 58th CND – endorsed by a wide range of civil society organisations, including the GDPO – provides background on the issue and explains why international scheduling would go against all the scientific evidence on the issue, be procedurally unsound and generate considerable negative public health impacts in parts of the world where there is already an acute crisis in essential surgery.